Molecular Diagnostics - Global Strategic Business Report
- Language: English
- 572 Pages
- Published: November 2012
- Region: World
Introduction
Scientific and technological developments are making the field of diagnostic imaging a growth industry. In 2007, the U.S. market for diagnostic imaging technologies was valued at more than $7 billion, and it is expected to exceed $8 billion by 2011. There are several trends that companies must heed to enjoy success in this market.
Get the Answers You Need to Shape Your Strategy
Diagnostic imaging comprises five major modalities: magnetic resonance imaging (MRI), ultrasound, X-ray, computed tomography (CT), and nuclear medicine (i.e., single-photon-emission-computed tomography [SPECT] and positron-emission tomography [PET]). What is the value of each of these fields today, and what are their growth prospects through 2011?
- Opportunities for growth in the industry are varied. One area is the development of hybrid modalities to combat competition and provide a more comprehensive and accurate diagnostic image. What hybrids have been developed, and which ones are still at the development stage? What are their respective advantages in the clinic?
- The diagnostic imaging market faces two key challenges. What are these challenges, and how might the industry
READ MORE >
Executive Summary
Strategic Considerations
Stakeholder Implications
Overview of the Diagnostic Imaging Market
Key Diagnostic Imaging Technologies
X Ray
Computed Tomography
Magnetic Resonance Imaging
Nuclear Medicine Imaging
Single-Photon-Electron-Computed Tomography
Positron-Emission Tomography
Ultrasound
Opportunities for Industry Growth
Improving Clinical Applications
Developing Hybrid Modalities
PET/CT
SPECT/CT
MRI/PET
Improving Imaging Agents
Advances in Information Technology
Picture Archiving and Communication System
Computer-Aided Detection/Diagnosis
Exploiting Nanotechnology
Key Challenges Faced by the Industry
Issues of Reimbursement
More Approvals for Tracer Agents
Company Profiles
GE Healthcare
Siemens Medical Solutions
Philips Medical Systems
Outlook
Appendix A. Imaging Agents in Clinical Development
Tables
1. Advantages and Disadvantages of Major Diagnostic Imaging Modalities
2. Select 99mTc Radiopharmaceuticals in Clinical Application
3. Diagnostic Imaging Collaborations of GE Healthcare, 2000-Present
4. Diagnostic Imaging Collaborations of Siemens Medical Solutions, 2000-Present
5. Diagnostic Imaging Collaborations of Philips Medical Systems, 2000-Present
6. Trends That Companies Should Heed for Future Success
Figures
1. The U.S. Diagnostic Imaging Market, 2005-2011
2. Market Value of Major Diagnostic Imaging Modalities, United States, 2005-2011
3. Clinical Applications of Diagnostic Imaging Techniques
4. Worldwide Revenues for Imaging Agents, 2007-2012
5. Leading Companies in the U.S. Diagnostic Imaging Market, 2006
6. Comparison of Leading Companies by Diagnostic Imaging Modality, United States,
2006
- Agfa Healthcare
- Bracco Diagnostics
- Commissure
- DR Systems
- Fujifi lm Medical Systems
- GE Healthcare
- General Electric Company
- Hitachi Medical Systems
- ImaRx Therapeutics
- Kodak Health Group
- Kereos
- Mallinckrodt
- Medipattern
- Philips Medical Systems
- Scottsdale Medical Imaging
- Siemens Healthcare Solutions
- Toshiba America Medical Systems
| Format | Properties | |
|---|---|---|
| Electronic (PDF) | The report will be emailed to you. The report is sent in PDF format. | This is a single user license, allowing one specific user access to the product. |
| Enterprisewide | The report will be emailed to you. The report is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |